Slingshot members are tracking this event:
BioLineRX (BLRX) Initiates Phase 2a Trial Evaluating BL-8040 + Merck's (MRK) KEYTRUDA in Treatment of Pancreatic Cancer
Slingshot Insights Explained
Sep 20, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Bl-8040, Keytruda, Pancreatic Cancer, Trial Initiation, Phase 2a